Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

58.17 +0.20 (+0.35%)
Official Closing Price Updated: 7:00 PM EDT, Oct 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
45 46 Next >
Sage Therapeutics, Roku, EchoStar And Other Big Stocks Moving Higher On Monday
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
1 Unpopular Stock that Deserves a Second Chance and 2 to Keep Off Your Radar
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
Hims & Hers Health Unusual Options Activity
 
Via Benzinga
A Look Into Hims & Hers Health Inc's Price Over Earnings
 
Via Benzinga
Hims & Hers Health Stock: A Deep Dive Into Analyst Perspectives (10 Ratings)
 
Via Benzinga
3 Reasons We Love Hims & Hers Health (HIMS)
The past six months have been a windfall for Hims & Hers Health’s shareholders. The company’s stock price has jumped 90%, hitting $57.16 per share. This was partly due to its solid quarterly results,... 
Via StockStory
Hims & Hers Stock Falls After Eli Lilly Rules Out Telehealth Tie-Up: Citi Calls It Aggressive Stance, Retail Turns Bearish
If Hims were to align with Lilly, Citi warned, it would signal the company has "thrown in the towel" on compounded medications. 
Via Stocktwits
Topics Regulatory Compliance
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Hims & Hers Stock Is Soaring Again. But Should You Buy the Stock?
Via The Motley Fool
Topics Supply Chain
Market Whales and Their Recent Bets on HIMS Options
 
Via Benzinga
Check Out What Whales Are Doing With HIMS
 
Via Benzinga
3 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Is Hims & Hers Health a Smart Buy Right Now?
Shares of Hims & Hers have crushed the market over the last year. 
Via The Motley Fool
Topics Artificial Intelligence
This Monster Growth Stock Is Up 167% in the Past Year and Disrupting the Healthcare Space
Via The Motley Fool
Topics Intellectual Property
Hims & Hers Stock: Buy the Dip or Wait It Out?
Hims & Hers stock is giving up some gains after announcing the acquisition of Zava, a European digital healthcare platform. 
Via MarketBeat
Topics World Trade
Hims & Hers Goes on a Buying Spree
Hims & Hers is expanding into Europe in a global push the company previewed earlier this year. 
Via The Motley Fool
HIMS & HERS HEALTH INC (NYSE:HIMS) – A Strong Growth Stock Meeting Minervini’s Criteria
HIMS & HERS HEALTH INC (NYSE:HIMS) is a high-growth telehealth stock meeting Minervini’s Trend Template with strong earnings, revenue growth, and bullish technicals. 
Via Chartmill
Hims & Hers ZAVA Acquisition Deal Expands Its Market Opportunity By $52 Billion: Analyst
Hims & Hers is acquiring digital health provider ZAVA to expand into Europe, aiming to boost revenue and international market reach by 2026. 
Via Benzinga
2 Incredible Growth Stocks to Buy Hand Over Fist
Via The Motley Fool
Topics Economy
3 Market-Beating Stocks Worth Your Attention
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the... 
Via StockStory
These stocks are making the most noise in today's session.
Curious about the most active stocks in today's session? Get a glimpse into the stocks that are generating the highest trading volume and capturing market attention. 
Via Chartmill
EXCLUSIVE: May's 20 Most-Searched Tickers On Benzinga Pro — Where Do Apple, Palantir, CoreWeave, Nvidia Rank?
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. 
Via Benzinga
Hims & Hers To Acquire European Telehealth Brand Zava As It Looks To Expand Globally
The Zava acquisition will enable Hims & Hers to expand its footprint in the U.K. and launch operations in countries such as Germany, France, and Ireland, with other markets expected to follow soon. 
Via Stocktwits
Topics Government
Hims & Hers Health Stock Is Rising Tuesday: What's Going On?
Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Tuesday after the company announced an acceleration of its global expansion through the acquisition of ZAVA. 
Via Benzinga
IBD 50's Hims & Hers Health Shoots Higher On A Key Takeover In Europe
The company hopes the deal will help it snag business in the UK, building a similar model to its U.S. platform. 
Via Investor's Business Daily
Topics ETFs
Hims & Hers Announces Plans to Acquire ZAVA, Accelerating Major European Growth Across the UK, Germany, France, and Ireland
From Hims & Hers
Via Business Wire
1 Healthcare Stock Worth Your Attention and 2 to Turn Down
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six... 
Via StockStory
Topics Stocks
Hims & Hers Faces Retail Skepticism After Layoffs, FDA Ban on Compounded Wegovy
The company said the layoffs were unrelated to the regulatory change. 
Via Stocktwits
Topics Law Enforcement Workforce
Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly
Eli Lilly is rapidly encroaching on Novo Nordisk's yearslong lead in GLP-1 drugs. Can Novo hold its tentpole position? 
Via Investor's Business Daily
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
45 46 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.